Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase. (Q45917946)

17 December 2017

title

Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase. (English)

1 reference

17 December 2017

1 reference

17 December 2017

author name string

Silvia K Schmidt

1 reference

17 December 2017

Anika Müller

1 reference

17 December 2017

Kathrin Heseler

1 reference

17 December 2017

Claudia Woite

1 reference

17 December 2017

Katrin Spekker

1 reference

17 December 2017

Walter Däubener

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

17 December 2017

European Journal of Immunology

published in

1 reference

17 December 2017

volume

1 reference

17 December 2017

issue

1 reference

17 December 2017

page(s)

2755-2764

1 reference

17 December 2017

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Tryptophan and the immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Evolution of vertebrate indoleamine 2,3-dioxygenases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Skin L-tryptophan-2,3-dioxygenase and rat hair growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Induction of tryptophan 2,3-dioxygenase in the mouse endometrium during implantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

The liver: a special case in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Combined lung and liver transplantation: the United States experience

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Dendritic cells, the liver, and transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

A new, simple, bioassay for human IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Induction of toxoplasmostasis in a human glioblastoma by interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939535

7 January 2021

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NRI1457

Identifiers

DOI

10.1002/EJI.200939535

1 reference

17 December 2017

1 reference

17 December 2017